{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:55:49Z","timestamp":1781805349966,"version":"3.54.5"},"reference-count":15,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:p>Sodium\u2013glucose cotransporter 2 (SGLT2) inhibitors are underutilized in people with type 2 diabetes after coronary artery bypass grafting (CABG). This study investigated the association of the presence of an endocrinologist on treatment teams with SGLT2 inhibitor prescription in patients with type 2 diabetes after CABG. The presence of an endocrinologist was associated with a more than twofold increase in the odds of obtaining an SGLT2 inhibitor prescription. This finding suggests that involving endocrinologists in these patients\u2019 postoperative care may improve prescription and use of SGLT2 inhibitors after CABG.<\/jats:p>","DOI":"10.2337\/cd24-0107","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:12:52Z","timestamp":1741270372000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Association of Endocrinologists on Clinical Care Team With Sodium\u2013Glucose Cotransporter 2 Inhibitor Prescription for People With Type 2 Diabetes After Coronary Artery Bypass Grafting: A Two-Center Study"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-6122","authenticated-orcid":false,"given":"Yangtian","family":"Yi","sequence":"first","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Kumar","sequence":"additional","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Mueller","sequence":"additional","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Houle","sequence":"additional","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arminder","family":"Jassar","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School 2 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Cornella","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School 3 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Schonberger","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Yale University 4 , New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bardia","sequence":"additional","affiliation":[{"name":"Deparment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School 1 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"2026061813313255300_B1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2026061813313255300_B2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2337\/dc11-2403","article-title":"Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an InteRnational Multicenter Registry","volume":"35","author":"Rana","year":"2012","journal-title":"Diabetes Care"},{"key":"2026061813313255300_B3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"2026061813313255300_B4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026061813313255300_B5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-8587(13)70089-5","article-title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","volume":"1","author":"Verma","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026061813313255300_B6","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary. A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"2026061813313255300_B7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026061813313255300_B8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026061813313255300_B9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"2026061813313255300_B10","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s00125-018-4644-9","article-title":"Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME\u00ae randomised trial","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"2026061813313255300_B11","doi-asserted-by":"crossref","first-page":"777083","DOI":"10.3389\/fphar.2021.777083","article-title":"Effects of sodium-glucose transporter 2 inhibitors (SGLT2-I) in patients with ischemic heart disease (IHD) treated by coronary artery bypass grafting via MiECC: inflammatory burden, and clinical outcomes at 5 years of follow-up","volume":"12","author":"Sardu","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026061813313255300_B12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc21-1815","article-title":"Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs","volume":"45","author":"Mahtta","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061813313255300_B13","doi-asserted-by":"crossref","first-page":"e023811","DOI":"10.1161\/JAHA.121.023811","article-title":"National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026061813313255300_B14","doi-asserted-by":"crossref","first-page":"E494","DOI":"10.9778\/cmajo.20220039","article-title":"Prescribing patterns and factors associated with sodium\u2013glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease","volume":"11","author":"Ozaki","year":"2023","journal-title":"CMAJ Open"},{"key":"2026061813313255300_B15","doi-asserted-by":"crossref","first-page":"109036","DOI":"10.1016\/j.diabres.2021.109036","article-title":"Prescribing of SGLT2 inhibitors in primary care: a qualitative study of general practitioners and endocrinologists","volume":"180","author":"Milder","year":"2021","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Clinical Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/43\/3\/409\/800381\/diaclincd240107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/43\/3\/409\/800381\/diaclincd240107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:31:39Z","timestamp":1781803899000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/clinical\/article\/43\/3\/409\/157948\/Association-of-Endocrinologists-on-Clinical-Care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,6]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.2337\/cd24-0107","relation":{},"ISSN":["0891-8929","1945-4953"],"issn-type":[{"value":"0891-8929","type":"print"},{"value":"1945-4953","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}